IONQ
IonQ, Inc.Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-06-18 | TOLEDANO GABRIELLE B |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 11, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.79 to $56.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
2,757 |
| 2026-06-18 | Raymond John w |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.18 to $56.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
3,815 |
| 2026-06-18 | Chou Kathryn K. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 11, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.80 to $56.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
2,757 |
| 2026-06-17 | TEUBER WILLIAM J JR |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a restricted stock unit ("RSU") award. The RSUs will vest in full on the earlier of (i) the day before the date of the following year's Annual Meeting or (ii) June 17, 2027, subject in all cases to the Reporting Person's continued service as a member of the Board of Directors through such vesting date. |
Common Stock
|
4,526 |
| 2026-06-17 | Scannell William F |
Chief Customer Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a restricted stock unit ("RSU") award. The RSUs will vest in full on the earlier of (i) the day before the date of the following year's Annual Meeting or (ii) June 17, 2027, subject in all cases to the Reporting Person's continued service as a member of the Board of Directors through such vesting date. |
Common Stock
|
4,526 |
| 2026-06-17 | TOLEDANO GABRIELLE B |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a restricted stock unit ("RSU") award. The RSUs will vest in full on the earlier of (i) the day before the date of the following year's Annual Meeting or (ii) June 17, 2027 subject in all cases to the Reporting Person's continued service as a member of the Board of Directors through such vesting date. |
Common Stock
|
4,526 |
| 2026-06-17 | Chou Kathryn K. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a restricted stock unit ("RSU") award. The RSUs will vest in full on the earlier of (i) the day before the date of the following year's Annual Meeting or (ii) June 17, 2027, subject in all cases to the Reporting Person's continued service as a member of the Board of Directors through such vesting date. |
Common Stock
|
4,526 |
| 2026-06-17 | FRANKOLA JIM |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a restricted stock unit ("RSU") award. The RSUs will vest in full on the earlier of (i) the day before the date of the following year's Annual Meeting or (ii) June 17, 2027, subject in all cases to the Reporting Person's continued service as a member of the Board of Directors through such vesting date. |
Common Stock
|
4,526 |
| 2026-06-16 | Singh Inder M |
Director |
Tax↓
Filing footnotes — Common Stock (Direct)
The reported securities were sold to satisfy the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs"). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.80 to $59.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
2,617 |
| 2026-06-11 | de Masi Niccolo |
Director, Co-Chief Executive Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
The reported securities were sold to satisfy the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs"). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.78 to $57.3, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
16,120 |
| 2026-06-11 | Singh Inder M |
Director |
Tax↓
Filing footnotes — Common Stock (Direct)
The reported securities were sold to satisfy the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs"). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.78 to $57.3, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
6,272 |
| 2026-06-11 | Cardillo Robert T. |
Director |
Tax↓
Filing footnotes — Common Stock (Direct)
The reported securities were sold to satisfy the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs"). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.78 to $57.3, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
904 |
| 2026-06-11 | DACIER PAUL T |
Director |
Tax↓
Filing footnotes — Common Stock (Direct)
The reported securities were sold to satisfy the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs"). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.78 to $57.3, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
4,110 |
| 2026-05-06 | Cardillo Robert T. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2025 and amended on June 13, 2025. |
Common Stock
|
3,773 |
| 2026-05-06 | Cardillo Robert T. |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2025 and amended on June 13, 2025. |
Common Stock
|
3,773 |
| 2026-05-06 | Cardillo Robert T. |
Director |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
One-third of the shares subject to the option vested or will vest on February 26, 2025 and each one-year anniversary thereafter, subject to the Reporting Person's continued service through each such vesting date. |
Stock Option (Right to Buy)
|
3,773 |
| 2026-04-16 | Cardillo Robert T. |
Director |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
One-third of the shares subject to the option vested or will vest on February 26, 2025 and each one-year anniversary thereafter, subject to the Reporting Person's continued service through each such vesting date. |
Stock Option (Right to Buy)
|
2,500 |
| 2026-04-16 | Cardillo Robert T. |
Director |
Sell↑
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2025 and amended on June 13, 2025. |
Common Stock
|
2,500 |
| 2026-04-16 | Cardillo Robert T. |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2025 and amended on June 13, 2025. |
Common Stock
|
2,500 |
| 2026-03-12 | Raymond John w |
Director |
Sell↓
|
Common Stock
|
2,800 |
| 2026-03-11 | de Masi Niccolo |
Director, Co-Chief Executive Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
The reported securities were sold to satisfy the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs"). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.69 to $35.87, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
20,785 |
| 2026-03-11 | DACIER PAUL T |
Director |
Tax↓
Filing footnotes — Common Stock (Direct)
The reported securities were sold to satisfy the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs"). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.69 to $35.87, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
6,181 |
| 2026-03-11 | Singh Inder M |
Director |
Tax↓
Filing footnotes — Common Stock (Direct)
The reported securities were sold to satisfy the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs"). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.69 to $35.87, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
8,134 |
| 2026-03-11 | Cardillo Robert T. |
Director |
Tax↓
Filing footnotes — Common Stock (Direct)
The reported securities were sold to satisfy the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs"). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.69 to $35.87, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
904 |
| 2026-03-02 | Cardillo Robert T. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a restricted stock unit ("RSU") award. The RSUs will vest over four years, with 1/16 of the total number of such shares vesting quarterly on each March 10, June 10, September 10 and December 10, subject to the Reporting Person continuing as a service provider through each such vesting date |
Common Stock
|
31,651 |
| 2026-02-27 | TEUBER WILLIAM J JR |
Director |
Buy↑
|
Common Stock
|
3,000 |
| 2026-02-27 | Cardillo Robert T. |
Director |
Tax↓
Filing footnotes — Common Stock (Direct)
The reported securities were sold to satisfy the Reporting Person's tax liability in connection with the vesting of restricted stock units. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.1392 to $39.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
3,071 |
| 2026-02-26 | Cardillo Robert T. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2025 and amended on June 13, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.00 to $39.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
5,165 |
| 2026-02-26 | Cardillo Robert T. |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2025 and amended on June 13, 2025. |
Common Stock
|
2,500 |
| 2026-02-26 | Cardillo Robert T. |
Director |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
One-third of the shares subject to the option vested or will vest on February 26, 2025 and each one-year anniversary thereafter, subject to the Reporting Person's continued service through each such vesting date. |
Stock Option (Right to Buy)
|
2,500 |
| 2026-02-24 | TOLEDANO GABRIELLE B |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 11, 2025. |
Common Stock
|
616 |
| 2026-02-20 | DACIER PAUL T |
Director |
Award↑
|
Common Stock
|
4,427 |
| 2026-02-20 | Singh Inder M |
Director |
Award↑
|
Common Stock
|
3,708 |
| 2026-02-20 | de Masi Niccolo |
Director, Co-Chief Executive Officer |
Award↑
Filing footnotes — Common Stock (Direct)
The reported securities are restricted stock units that vest in full on March 10, 2026, subject to the Reporting Person continuing as a service provider through such date. |
Common Stock
|
11,556 |
| 2025-12-22 | Chou Kathryn K. |
Director |
Convert↓
Filing footnotes — Stock Option (right to buy) (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 11, 2025. This option, originally for 63,900 shares, vested in three equal annual installments commencing July 11, 2023. |
Stock Option (right to buy)
|
5,000 |
| 2025-12-22 | Chou Kathryn K. |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 11, 2025. |
Common Stock
|
5,000 |
| 2025-12-22 | Chou Kathryn K. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 11, 2025. |
Common Stock
|
5,000 |
| 2025-12-11 | Chou Kathryn K. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 11, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.16 to $52.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
20,000 |
| 2025-12-11 | de Masi Niccolo |
Director, Co-Chief Executive Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
The reported securities were sold to satisfy the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs"). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.09 to $52.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
16,290 |
| 2025-12-11 | DACIER PAUL T |
Director |
Tax↓
Filing footnotes — Common Stock (Direct)
The reported securities were sold to satisfy the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs"). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.09 to $52.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
4,132 |
| 2025-12-11 | Chou Kathryn K. |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 11, 2025. |
Common Stock
|
20,000 |
| 2025-12-11 | Singh Inder M |
Director |
Tax↓
Filing footnotes — Common Stock (Direct)
The reported securities were sold to satisfy the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs"). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.09 to $52.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
12,553 |
| 2025-12-11 | Chou Kathryn K. |
Director |
Convert↓
Filing footnotes — Stock Option (right to buy) (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 11, 2025. This option, originally for 63,900 shares, vests in three equal annual installments commencing July 11, 2023, subject to the Reporting Person's continued service through each such vesting date. |
Stock Option (right to buy)
|
20,000 |
| 2025-12-11 | Millard Scott Francis |
Chief Revenue Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
The reported securities were sold to satisfy the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs"). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.09 to $52.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
19,586 |
| 2025-11-20 | Alameddine Rima |
Chief Revenue Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2025 and as amended on August 21, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.59 to $49.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
100,000 |
| 2025-11-17 | Raymond John w |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a restricted stock unit ("RSU") award. The RSUs will vest over four years, with 1/16th of the total number of shares underlying the award vesting quarterly on each March 10, June 10, September 10 and December 10, subject to the Reporting Person continuing as a service provider through each such vesting date. |
Common Stock
|
83,700 |
| 2025-11-11 | TEUBER WILLIAM J JR |
Director |
Buy↑
|
Common Stock
|
2,000 |
| 2025-11-10 | Singh Inder M |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a restricted stock unit ("RSU") award. The RSUs will vest in full on September 10, 2027, generally subject to the Reporting Person continuing as a service provider through such date. |
Common Stock
|
274,947 |
| 2025-10-06 | Acosta Dean P. |
CCA & GRO |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a restricted stock unit ("RSU") award. The RSUs will vest over four years, with 25% of the total number of shares underlying the award vesting on December 10, 2026 and 1/16 of the total number of such shares vesting quarterly thereafter on each subsequent March 10, June 10, September 10 and December 10, subject to the Reporting Person continuing as a service provider through each such vesting date. |
Common Stock
|
75,959 |
| 2025-10-06 | Acosta Dean P. |
CCA & GRO |
Other↑
|
No Securities Owned
|
0 |